Successful eradication of mucormycosis occurring in a pulmonary allograft

Journal of Heart and Lung Transplantation

Volumn 18, Issue 8, 1999, Pages 801-804

  Hunstad, David A ^a   Cohen, Alan H ^b   St Geme III, Joseph W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia Pediatric Pulmonology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; INSULIN; OKT 3; PREDNISONE; TACROLIMUS;

ADOLESCENT; ARTICLE; BACTEREMIA; CASE REPORT; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MUCORMYCOSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG; LUNG DISEASES, FUNGAL; MUCORALES; MUCORMYCOSIS; PNEUMONECTOMY; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032833724     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00033-9     Document Type: Article

References (11)

1. Kline M. Mucormycosis in children review of the literature and report of cases . Pediatr Infect Dis J. 4:1985;672-676.
2. Kramer M.R., Marshall S.E., Starnes V.A., Gamberg P., Amitai Z., Theodore J. Infectious complications in heart-lung transplantation analysis of 200 episodes . Arch Intern Med. 153:1993;2010-2016.
3. Nampoory M.R.N., Khan Z.U., Johny K.V., et al. Invasive fungal infections in renal transplant recipients. J Infection. 33:1996;95-101.
4. Patel R., Portela D., Badley A., et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation. 62:1996;926-934.
5. Brown R.S., Lake J.R., Katzman B.A., et al. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 61:1996;666-669.
6. Hetherington S.V. Zygomycetes, agents of mucormycosis, and related species. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. 1st ed. 1997;1336 Churchill Livingstone, New York.
7. Selby R., Ramirez C.B., Singh R., et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg. 132:1997;304-310.
8. Studemeister A.E., Kozak K., Garrity E., Venezio F.R. Survival of a heart transplant recipient after pulmonary cavitary mucormycosis. J Heart Transplant. 7:1988;159-161.
9. Mowat A.G., Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 284:1971;621-627.
10. Artis W.M., Fountain J.A., Delcher H.K., Jones H.E. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis; transferrin and iron availability. Diabetes. 31:1982;1109-1114.
11. Paya C.V. Opportunistic infections risk factor or virus-associated complication? Transplant Proc. 26:(suppl. 1):1994;12-15.